CA2289416C - Dispositif et methode pour l'analyse d'un echantillon biologique - Google Patents
Dispositif et methode pour l'analyse d'un echantillon biologique Download PDFInfo
- Publication number
- CA2289416C CA2289416C CA 2289416 CA2289416A CA2289416C CA 2289416 C CA2289416 C CA 2289416C CA 2289416 CA2289416 CA 2289416 CA 2289416 A CA2289416 A CA 2289416A CA 2289416 C CA2289416 C CA 2289416C
- Authority
- CA
- Canada
- Prior art keywords
- fluid
- sample
- microspheres
- capillary
- fluid component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title claims abstract description 92
- 239000012530 fluid Substances 0.000 claims abstract description 294
- 239000004005 microsphere Substances 0.000 claims abstract description 189
- 239000012491 analyte Substances 0.000 claims abstract description 95
- 238000003556 assay Methods 0.000 claims abstract description 95
- 238000000926 separation method Methods 0.000 claims abstract description 62
- 230000009471 action Effects 0.000 claims abstract description 25
- 210000004369 blood Anatomy 0.000 claims description 68
- 239000008280 blood Substances 0.000 claims description 68
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 61
- 239000002245 particle Substances 0.000 claims description 56
- 239000003153 chemical reaction reagent Substances 0.000 claims description 44
- 238000004891 communication Methods 0.000 claims description 24
- 102000004169 proteins and genes Human genes 0.000 claims description 22
- 108090000623 proteins and genes Proteins 0.000 claims description 22
- 239000000377 silicon dioxide Substances 0.000 claims description 21
- 238000004587 chromatography analysis Methods 0.000 claims description 15
- 238000013528 artificial neural network Methods 0.000 claims description 14
- 239000000020 Nitrocellulose Substances 0.000 claims description 12
- 229920001220 nitrocellulos Polymers 0.000 claims description 12
- 239000000427 antigen Substances 0.000 claims description 9
- 238000004422 calculation algorithm Methods 0.000 claims description 9
- 238000004458 analytical method Methods 0.000 claims description 8
- 102000036639 antigens Human genes 0.000 claims description 8
- 108091007433 antigens Proteins 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 6
- -1 antibodies Proteins 0.000 claims description 5
- 230000027455 binding Effects 0.000 claims description 5
- 230000005540 biological transmission Effects 0.000 claims description 5
- 229940079593 drug Drugs 0.000 claims description 5
- 239000002184 metal Substances 0.000 claims description 4
- 229910052751 metal Inorganic materials 0.000 claims description 4
- 102000039446 nucleic acids Human genes 0.000 claims description 4
- 108020004707 nucleic acids Proteins 0.000 claims description 4
- 150000007523 nucleic acids Chemical class 0.000 claims description 4
- 150000002739 metals Chemical class 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims 2
- 150000002391 heterocyclic compounds Chemical class 0.000 claims 2
- 150000002632 lipids Chemical class 0.000 claims 2
- 150000003431 steroids Chemical class 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 230000002285 radioactive effect Effects 0.000 claims 1
- 238000001514 detection method Methods 0.000 abstract description 34
- 230000001413 cellular effect Effects 0.000 abstract description 17
- 238000011156 evaluation Methods 0.000 abstract description 4
- 238000003018 immunoassay Methods 0.000 abstract description 4
- 238000007813 chromatographic assay Methods 0.000 abstract description 2
- 239000011324 bead Substances 0.000 description 133
- 238000012360 testing method Methods 0.000 description 86
- 238000000018 DNA microarray Methods 0.000 description 35
- 241000894006 Bacteria Species 0.000 description 23
- 239000000725 suspension Substances 0.000 description 20
- 239000004576 sand Substances 0.000 description 18
- 239000011152 fibreglass Substances 0.000 description 13
- 230000008901 benefit Effects 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- 235000008429 bread Nutrition 0.000 description 10
- 210000003743 erythrocyte Anatomy 0.000 description 10
- 235000013339 cereals Nutrition 0.000 description 9
- 230000033001 locomotion Effects 0.000 description 9
- 230000008859 change Effects 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 8
- 210000003608 fece Anatomy 0.000 description 8
- 238000001914 filtration Methods 0.000 description 8
- 239000011521 glass Substances 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 235000013618 yogurt Nutrition 0.000 description 8
- 241000588724 Escherichia coli Species 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 239000010410 layer Substances 0.000 description 7
- 239000011148 porous material Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 238000012546 transfer Methods 0.000 description 7
- 244000005700 microbiome Species 0.000 description 6
- 239000004793 Polystyrene Substances 0.000 description 5
- 239000007795 chemical reaction product Substances 0.000 description 5
- 230000015271 coagulation Effects 0.000 description 5
- 238000005345 coagulation Methods 0.000 description 5
- 238000002372 labelling Methods 0.000 description 5
- 239000004816 latex Substances 0.000 description 5
- 229920000126 latex Polymers 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- 229920002223 polystyrene Polymers 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 230000009870 specific binding Effects 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 210000002569 neuron Anatomy 0.000 description 4
- 238000007639 printing Methods 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 125000006850 spacer group Chemical group 0.000 description 4
- 238000012549 training Methods 0.000 description 4
- 239000013598 vector Substances 0.000 description 4
- 102000004506 Blood Proteins Human genes 0.000 description 3
- 108010017384 Blood Proteins Proteins 0.000 description 3
- 102000011022 Chorionic Gonadotropin Human genes 0.000 description 3
- 108010062540 Chorionic Gonadotropin Proteins 0.000 description 3
- 241000186660 Lactobacillus Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 229940084986 human chorionic gonadotropin Drugs 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 238000005192 partition Methods 0.000 description 3
- 238000000638 solvent extraction Methods 0.000 description 3
- 238000011895 specific detection Methods 0.000 description 3
- 230000001052 transient effect Effects 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- PGOHTUIFYSHAQG-LJSDBVFPSA-N (2S)-6-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-sulfanylpropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]hexanoic acid Chemical compound CSCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O PGOHTUIFYSHAQG-LJSDBVFPSA-N 0.000 description 2
- 102000002262 Thromboplastin Human genes 0.000 description 2
- 108010000499 Thromboplastin Proteins 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 238000013096 assay test Methods 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 201000009409 embryonal rhabdomyosarcoma Diseases 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000013307 optical fiber Substances 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000004393 prognosis Methods 0.000 description 2
- 238000004445 quantitative analysis Methods 0.000 description 2
- 238000012207 quantitative assay Methods 0.000 description 2
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 241000186781 Listeria Species 0.000 description 1
- 229920001410 Microfiber Polymers 0.000 description 1
- 208000018262 Peripheral vascular disease Diseases 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 239000006194 liquid suspension Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000007620 mathematical function Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000003658 microfiber Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000001483 mobilizing effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000002572 performance enhancing substance Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 238000009597 pregnancy test Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- 238000012205 qualitative assay Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000012502 risk assessment Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000002951 street drug Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Sampling And Sample Adjustment (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2289416 CA2289416C (fr) | 1998-11-16 | 1999-11-12 | Dispositif et methode pour l'analyse d'un echantillon biologique |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA2,254,223 | 1998-11-16 | ||
| CA002254223A CA2254223A1 (fr) | 1998-11-16 | 1998-11-16 | Dispositif et methode pour l'analyse d'un echantillon biologique |
| US09/335,732 | 1999-06-18 | ||
| US09/335,732 US6403384B1 (en) | 1998-11-16 | 1999-06-18 | Device and method for analyzing a biologic sample |
| CA 2289416 CA2289416C (fr) | 1998-11-16 | 1999-11-12 | Dispositif et methode pour l'analyse d'un echantillon biologique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2289416A1 CA2289416A1 (fr) | 2000-05-16 |
| CA2289416C true CA2289416C (fr) | 2005-02-15 |
Family
ID=31720870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 2289416 Expired - Lifetime CA2289416C (fr) | 1998-11-16 | 1999-11-12 | Dispositif et methode pour l'analyse d'un echantillon biologique |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2289416C (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111562164A (zh) * | 2020-05-15 | 2020-08-21 | 河南赛诺特生物技术有限公司 | 一种液盖膜 |
| CN114842091B (zh) * | 2022-04-29 | 2023-05-23 | 广东工业大学 | 一种双目鸡蛋尺寸流水线测定方法 |
-
1999
- 1999-11-12 CA CA 2289416 patent/CA2289416C/fr not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2289416A1 (fr) | 2000-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6403384B1 (en) | Device and method for analyzing a biologic sample | |
| JP4544498B2 (ja) | 生物学的サンプルの分析装置および方法 | |
| WO2000078917A1 (fr) | Dispositif et procede d'analyse d'un echantillon biologique | |
| EP1891447B1 (fr) | Procédés et dispositifs de détermination par écoulement latéral en deux étapes | |
| US7700372B2 (en) | Portable diagnostic device and method for determining temporal variations in concentrations | |
| CA2654931C (fr) | Dispositif d'essai biologique et methode de fonctions de controle ameliorees | |
| KR101096924B1 (ko) | 단방향 유동 검정장치 | |
| CN101547641B (zh) | 侧向流检测设备 | |
| US7569397B2 (en) | Immunoassay devices and use thereof | |
| US6812038B1 (en) | Assay device and use thereof | |
| US20110124130A1 (en) | Device and method for analysis of samples with depletion of analyte content | |
| US8202487B2 (en) | Multiple analyte assay devices | |
| CA2469935A1 (fr) | Procede de test de diagnostic | |
| JP2006511810A (ja) | 被検物をマイクロ流体デバイスの多チャネルに分割する方法及び装置 | |
| JPH05180841A (ja) | 固相アッセイ装置 | |
| KR102371415B1 (ko) | 다수의 미터링 챔버들을 구비한 회전가능한 카트리지 | |
| WO2009152209A2 (fr) | Test de détection d'analyte visuel/par fluorescence combiné | |
| CA2289416C (fr) | Dispositif et methode pour l'analyse d'un echantillon biologique | |
| CA2350789A1 (fr) | Dispositif et procede d'analyse d'un echantillon biologique | |
| KR20150078742A (ko) | 패턴 경로를 포함하는 면역 크로마토그래피 분석 센서 및 이를 이용한 분석 방법 | |
| CN203561636U (zh) | 定向流免疫层析装置 | |
| CN101175996A (zh) | 半定量免疫色谱装置 | |
| AU2007261759B2 (en) | Assay device | |
| AU2006202177A1 (en) | Multiple analyte assay devices |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKEX | Expiry |
Effective date: 20191112 |